1. Radak, Mehran, Fallahi, Hossein. 2023. Zbp1 gene: a modulator of multiple aging hallmarks as potential therapeutic target for age-related diseases. In Biogerontology, 24, 831-844. doi:10.1007/s10522-023-10039-w. https://pubmed.ncbi.nlm.nih.gov/37199888/
2. Karki, Rajendra, Sundaram, Balamurugan, Sharma, Bhesh Raj, Vogel, Peter, Kanneganti, Thirumala-Devi. . ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis. In Cell reports, 37, 109858. doi:10.1016/j.celrep.2021.109858. https://pubmed.ncbi.nlm.nih.gov/34686350/
3. Zhang, Ting, Yin, Chaoran, Fedorov, Aleksandr, Herbert, Alan, Balachandran, Siddharth. 2022. ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis. In Nature, 606, 594-602. doi:10.1038/s41586-022-04753-7. https://pubmed.ncbi.nlm.nih.gov/35614224/
4. Yang, Daowei, Liang, Yaoji, Zhao, Shubo, Wu, Su-Qin, Han, Jiahuai. 2019. ZBP1 mediates interferon-induced necroptosis. In Cellular & molecular immunology, 17, 356-368. doi:10.1038/s41423-019-0237-x. https://pubmed.ncbi.nlm.nih.gov/31076724/
5. Rodriguez, Diego A, Quarato, Giovanni, Liedmann, Swantje, Balachandran, Siddharth, Green, Douglas R. 2022. Caspase-8 and FADD prevent spontaneous ZBP1 expression and necroptosis. In Proceedings of the National Academy of Sciences of the United States of America, 119, e2207240119. doi:10.1073/pnas.2207240119. https://pubmed.ncbi.nlm.nih.gov/36191211/